Edgar Filing: LAI GOLDMAN MYLA

Ownership Submission

FORM 4

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0287

Expires:

January 31, 2005

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

LAI GOLDMAN MYLA

2. Issuer Name and Ticker or Trading Symbol
LABORATORY CORP OF AMERICA HOLDINGS [LH]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

_____ Director	_____ 10% Owner
__X__ Officer (give title below)	_____ Other (specify below)
EVP & Chief Medical Officer

(Last)

(First)

(Middle)

430 SOUTH SPRING STREET

3. Date of Earliest Transaction (Month/Day/Year)
05/04/2005

(Street)

BURLINGTON, NC 27215

4. If Amendment, Date Original Filed(Month/Day/Year)

6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock ⁽¹⁾	05/04/2005		M		16,800	A	$ 24.46	53,929.074 ⁽²⁾	D
Common Stock ⁽¹⁾	05/04/2005		S		1,100	D	$ 50.25	52,829.074 ⁽²⁾	D
Common Stock ⁽¹⁾	05/04/2005		S		100	D	$ 50.24	52,729.074 ⁽²⁾	D
Common Stock ⁽¹⁾	05/04/2005		S		4,900	D	$ 50.21	47,829.074 ⁽²⁾	D
Common Stock ⁽¹⁾	05/04/2005		S		700	D	$ 50.14	47,129.074 ⁽²⁾	D
Common Stock ⁽¹⁾	05/04/2005		S		4,300	D	$ 50.13	42,829.074 ⁽²⁾	D
Common Stock ⁽¹⁾	05/04/2005		S		400	D	$ 50.11	42,429.074 ⁽²⁾	D
Common Stock ⁽¹⁾	05/04/2005		S		4,100	D	$ 50.1	38,329.074 ⁽²⁾	D
Common Stock ⁽¹⁾	05/04/2005		S		1,200	D	$ 50.08	37,129.074 ⁽²⁾	D
Common Stock								2,000 ⁽³⁾	I	By Daughter

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security
(Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code
(Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date
(Month/Day/Year)

7. Title and Amount of Underlying Securities
(Instr. 3 and 4)

8. Price of Derivative Security
(Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)

11. Nature of Indirect Beneficial Ownership
(Instr. 4)

Code

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Non-qualified Stock Options ⁽¹⁾ ⁽⁴⁾

$ 24.46

05/04/2005

16,800

02/19/2004⁽⁵⁾

02/19/2013

Common Stock

16,800

$ 24.46

16,800

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
LAI GOLDMAN MYLA 430 SOUTH SPRING STREET BURLINGTON, NC 27215			EVP & Chief Medical Officer

Signatures

By: /s/ BRADFORD T. SMITH, Attorney-in-Fact for Myla Lai-Goldman		05/06/2005
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.
(2)	Amount shown reflects a 2-for-1 stock split effective on May 10, 2002.
(3)	Beneficial ownership of these shares is disclaimed.
(4)	Common stock purchase option granted under the Laboratory Corporation of America Holdings 2000 Stock Incentive Plan.
(5)	The option vests in three equal annual installments beginning on the date reflected in this column.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.